Market Introduction
This research report provides insights into the South & Central AmericaCancer Vaccines market. The cancer vaccine is a vaccine which either treats existing cancer or prevents cancer from developing. Established cancer treatment vaccines are known as therapeutic cancer vaccines. Some / many of the vaccines are "autologous," are made from patient samples, and are unique to that patient. Additionally the cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. For instance, Cervarix, Gardasil, Gardasil-9 and Hepatitis B (HBV) vaccine (HEPLISAV-B) are Preventive Cancer Vaccines. Whereas, Bacillus Calmette-Guérin (BCG), Sipuleucel-T (Provenge) are Therapeutic Cancer Vaccines
Market Overview and Dynamics
The South and Central America cancer vaccines market was valued at US$ 191.89 million in 2019 and is projected to reach US$ 627.49 million by 2027; it is expected to grow at a CAGR of 16.3% during the forecast period.Factors driving demand growth include a rise in the prevalence of cancer worldwide and steps taken by South & Central Americaan health research organisations and major players in cancer vaccines. COVID19 has had a substantial effect on the industry due to delays in the supply chain and locking conditions. However, problems in the cancer vaccine industry, such as higher prices for cancer vaccines, impede market growth.
Key Market Segments
In terms of technology, the recombinant cancer vaccinessegment held the largest share of the market in 2019; and also is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the preventive cancer vaccine segment held a larger share of the market in 2019and also is estimated to register a higher market sharein the market during the forecast period. Likewise, in terms of end user, the pediatricssegment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Canadian MedTech Manufacturers’ Alliance are some of the major primary and secondary sources for the South & Central Americacancer vaccines market included in the report.
Reasons to buy the report
South & Central AmericaCancer vaccines Market Segmentation
By Technology
South & Central America Cancer Vaccines Market – By Type
South & Central America Cancer Vaccines Market – By Indication
South & Central America Cancer Vaccines Market– By End Use
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 191.89 Million |
| Market Size by 2027 | US$ 627.49 Million |
| CAGR (2019 - 2027) | 16.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Cancer Vaccines Market is valued at US$ 191.89 Million in 2019, it is projected to reach US$ 627.49 Million by 2027.
As per our report South and Central America Cancer Vaccines Market, the market size is valued at US$ 191.89 Million in 2019, projecting it to reach US$ 627.49 Million by 2027. This translates to a CAGR of approximately 16.3% during the forecast period.
The South and Central America Cancer Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Cancer Vaccines Market report:
The South and Central America Cancer Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Cancer Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Cancer Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)